loading
Senseonics Holdings Inc stock is currently priced at $0.4202, with a 24-hour trading volume of 627.38K. It has seen a +0.22% increased in the last 24 hours and a -24.35% declined in the past month. The chart indicates a potential bullish trend, as the stock is above the $0.4165 pivot point. If it approaches the $0.4313 resistance level, significant changes may occur.
Previous Close:
$0.4182
Open:
$0.425
24h Volume:
627.38K
Market Cap:
$225.68M
Revenue:
$22.39M
Net Income/Loss:
$-60.39M
P/E Ratio:
-2.3113
EPS:
-0.1818
Net Cash Flow:
$-70.51M
1W Performance:
+4.98%
1M Performance:
-24.35%
6M Performance:
-16.18%
1Y Performance:
-24.02%
1D Range:
Value
$0.416
$0.4279
52W Range:
Value
$0.3838
$1.05

Senseonics Holdings Inc Stock (SENS) Company Profile

Name
Name
Senseonics Holdings Inc
Name
Phone
301-515-7260
Name
Address
20451 Seneca Meadows Parkway, Germantown, MD
Name
Employee
94
Name
Twitter
@senseonics
Name
Next Earnings Date
2024-05-22
Name
Latest SEC Filings
Name
SENS's Discussions on Twitter

Senseonics Holdings Inc Stock (SENS) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-19-21 Initiated H.C. Wainwright Buy
Apr-01-21 Downgrade SVB Leerink Outperform → Mkt Perform
Mar-05-21 Downgrade Raymond James Mkt Perform → Underperform
Jan-21-21 Downgrade BTIG Research Buy → Neutral
Jan-20-21 Downgrade Craig Hallum Hold → Sell
Aug-11-20 Upgrade BTIG Research Neutral → Buy
Aug-11-20 Upgrade Craig Hallum Sell → Hold
Mar-13-20 Downgrade BTIG Research Buy → Neutral
Mar-13-20 Downgrade Guggenheim Buy → Neutral
Nov-13-19 Downgrade Canaccord Genuity Buy → Hold
Nov-13-19 Downgrade Craig Hallum Buy → Hold
Oct-23-19 Initiated Stifel Buy
Jul-05-19 Downgrade Raymond James Outperform → Mkt Perform
Jan-29-19 Initiated Piper Jaffray Neutral
Aug-24-18 Initiated Dougherty & Company Buy
View All

Senseonics Holdings Inc Stock (SENS) Financials Data

Senseonics Holdings Inc (SENS) Revenue 2024

SENS reported a revenue (TTM) of $22.39 million for the quarter ending December 31, 2023, a +36.62% rise year-over-year.
loading

Senseonics Holdings Inc (SENS) Net Income 2024

SENS net income (TTM) was -$60.39 million for the quarter ending December 31, 2023, a -142.49% decrease year-over-year.
loading

Senseonics Holdings Inc (SENS) Cash Flow 2024

SENS recorded a free cash flow (TTM) of -$70.51 million for the quarter ending December 31, 2023, a -5.84% decrease year-over-year.
loading

Senseonics Holdings Inc (SENS) Earnings per Share 2024

SENS earnings per share (TTM) was -$0.1118 for the quarter ending December 31, 2023, a +44.10% growth year-over-year.
loading
Senseonics Holdings, Inc., a medical technology company, designs, develops, and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems that is designed to continually and accurately measure glucose levels in people with diabetes for a period of up to 90 and 180 days. The company has a research and development license agreement with TypeZero Technologies, Inc. and Roche Diabetes Care, Inc. to develop a closed loop diabetes management system that allow users to automatically maintain tight glucose control while avoiding hypoglycemia. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
medical_devices PHG
$21.14
price up icon 2.05%
medical_devices STE
$203.86
price up icon 1.11%
$309.55
price down icon 0.34%
medical_devices ZBH
$119.71
price down icon 0.03%
$126.08
price down icon 8.68%
medical_devices EW
$86.04
price down icon 2.24%
Cap:     |  Volume (24h):